Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban) are necessary to assess the role of each agent in stroke prevention in patients with AF.

and Pfizer/Bristol-Myers Squibb's Eliquis (apixaban) – if treatment with the drugs leads to life-threatening or uncontrolled bleeding complications. On the positive side, members of the Cellular ...

The OCEANIC-AF is comparing asundexian to Pfizer and Bristol-Myers Squibb’s widely-used oral Factor Xa inhibitor Eliquis (apixaban) in AF patients at risk of a stroke, to see how well they ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

Experts voice their concerns amidst the National Institutes of Health (NIH) decision to halt over 40 grants dedicated to vaccine hesitancy and acceptance research. HealthDay News — The National ...